Jane Street’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Jane Street’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$974K	Hold	14,700	–	–	﹤0.01%	6614
2026 Q1	$795K	Buy	+14,700	New	+$819K	﹤0.01%	6995
2018 Q4	–	Sell	-6,500	Closed	-$316K	–	5831
2018 Q3	$316K	Hold	6,500	–	–	﹤0.01%	4158
2018 Q2	$280K	Buy	+6,500	New	+$273K	﹤0.01%	4198

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Jane Street's XPH Position: Q2 2026 in Review

Jane Street reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 73% in Q2 2026, selling an estimated $999K and leaving 6,253 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #8469.

Jane Street first reported a position in XPH in Q1 2014 and has held it in 25 quarters since. The position peaked at $4.15M in Q3 2015. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Jane Street held 6,253 shares of State Street SPDR S&P Pharmaceuticals ETF worth $414K as of Q2 2026.
Jane Street sold 17,053 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $999K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8469 holding.
Jane Street first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and has held it in 25 quarters since.
Jane Street's State Street SPDR S&P Pharmaceuticals ETF position peaked at $4.15M in Q3 2015.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.